- 03
- January
2012
A recent study published in the British Medical Journal (BMJ) has determined that just over half of people who participate in medical panels that make treatment guidelines have a conflict of interest. The study looked at the prevalence of conflicts of interests among the member of medical panels in the United States and Canada that published guidelines for treating diabetes and cholesterol. In all, 52 percent of the 288 members of the panels studied had conflicts.
Conflicts of interest arise for panel members when they or their family members are compensated either monetarily or through other means. Due to these benefits received, the panel members are more likely to develop guidelines that favor or approve the use of prescription drugs or medical devices manufactured by the giver of the benefits.








